Martin Auster
Stock Analyst at Raymond James
(4.45)
# 1,153
Out of 5,036 analysts
211
Total ratings
47.7%
Success rate
13%
Average return
Main Sectors:
Stocks Rated by Martin Auster
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Maintained: Buy | $40 → $37 | $16.23 | +127.97% | 6 | Sep 24, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $271 → $287 | $223.13 | +28.62% | 2 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $60 → $72 | $49.85 | +44.43% | 6 | Sep 14, 2026 | |
| EVMN Evommune | Reiterated: Buy | $40 → $18 | $8.77 | +105.25% | 3 | Sep 9, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | $18 | $6.36 | +183.02% | 1 | Aug 24, 2026 | |
| SEPN Septerna | Rated: Buy | $53 → $49 | $38.45 | +27.44% | 3 | Aug 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $468 → $420 | $246.51 | +70.38% | 5 | Jul 31, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $28 → $21 | $6.99 | +200.64% | 2 | Jul 31, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $5 | $1.25 | +301.61% | 1 | Jun 8, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $46 → $66 | $41.05 | +60.78% | 4 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $1.75 | +300.00% | 2 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $65.71 | - | 4 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $81 | $24.98 | +224.26% | 2 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $88.17 | -9.27% | 1 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $56 | $28.09 | +99.36% | 2 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $117 | $66.09 | +77.03% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $3.95 | +558.23% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $65.81 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $6 | $49.42 | n/a | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 → $100 | $62.21 | n/a | 14 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $3.81 | n/a | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $12 | $20.44 | n/a | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $8 | $8.02 | n/a | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 → $58 | $26.11 | n/a | 6 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $156 → $72 | $18.95 | n/a | 23 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $169 → $196 | $489.42 | n/a | 17 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $98 | $1.47 | n/a | 5 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $99 | $14.88 | n/a | 15 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $118.34 | n/a | 17 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $54 | $62.34 | n/a | 12 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $78 | $42.76 | n/a | 5 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $12 | $4.27 | n/a | 9 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $24 | $12.33 | n/a | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $43 | $11.04 | n/a | 4 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $525.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 | $30.15 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $50.77 | n/a | 8 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $4 | $0.0001 | n/a | 3 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.8239 | n/a | 1 | Jan 18, 2018 |
Dyne Therapeutics
Sep 24, 2026
Maintained: Buy
Price Target: $40 → $37
Current: $16.23
Upside: +127.97%
Ascendis Pharma
Sep 15, 2026
Reiterated: Buy
Price Target: $271 → $287
Current: $223.13
Upside: +28.62%
Scholar Rock Holding
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $72
Current: $49.85
Upside: +44.43%
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $40 → $18
Current: $8.77
Upside: +105.25%
Shattuck Labs
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $6.36
Upside: +183.02%
Septerna
Aug 11, 2026
Rated: Buy
Price Target: $53 → $49
Current: $38.45
Upside: +27.44%
Alnylam Pharmaceuticals
Jul 31, 2026
Reiterated: Buy
Price Target: $468 → $420
Current: $246.51
Upside: +70.38%
Phathom Pharmaceuticals
Jul 31, 2026
Reiterated: Buy
Price Target: $28 → $21
Current: $6.99
Upside: +200.64%
iBio, Inc.
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.25
Upside: +301.61%
Edgewise Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $46 → $66
Current: $41.05
Upside: +60.78%
May 28, 2026
Reiterated: Buy
Price Target: $6 → $7
Current: $1.75
Upside: +300.00%
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $65.71
Upside: -
May 26, 2026
Reiterated: Buy
Price Target: $76 → $81
Current: $24.98
Upside: +224.26%
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $88.17
Upside: -9.27%
Mar 25, 2026
Reiterated: Buy
Price Target: $48 → $56
Current: $28.09
Upside: +99.36%
Jan 13, 2026
Reiterated: Buy
Price Target: $108 → $117
Current: $66.09
Upside: +77.03%
Jan 13, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $3.95
Upside: +558.23%
Jul 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $65.81
Upside: n/a
Nov 16, 2021
Reiterated: Buy
Price Target: $26 → $6
Current: $49.42
Upside: n/a
Oct 28, 2021
Reiterated: Buy
Price Target: $102 → $100
Current: $62.21
Upside: n/a
Mar 22, 2021
Initiated Coverage: Buy
Price Target: $26
Current: $3.81
Upside: n/a
Mar 16, 2021
Reiterated: Buy
Price Target: $29 → $12
Current: $20.44
Upside: n/a
Mar 16, 2021
Reiterated: Hold
Price Target: $7 → $8
Current: $8.02
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $49 → $58
Current: $26.11
Upside: n/a
Mar 2, 2021
Reiterated: Hold
Price Target: $156 → $72
Current: $18.95
Upside: n/a
Feb 22, 2021
Reiterated: Buy
Price Target: $169 → $196
Current: $489.42
Upside: n/a
Feb 11, 2021
Reiterated: Buy
Price Target: $62 → $98
Current: $1.47
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $64 → $99
Current: $14.88
Upside: n/a
Jan 19, 2021
Reiterated: Buy
Price Target: $50 → $60
Current: $118.34
Upside: n/a
Jan 11, 2021
Reiterated: Hold
Price Target: $53 → $54
Current: $62.34
Upside: n/a
Nov 20, 2020
Reiterated: Buy
Price Target: $76 → $78
Current: $42.76
Upside: n/a
Nov 6, 2020
Reiterated: Hold
Price Target: $11 → $12
Current: $4.27
Upside: n/a
Nov 5, 2020
Reiterated: Hold
Price Target: $21 → $24
Current: $12.33
Upside: n/a
Oct 8, 2020
Reiterated: Buy
Price Target: $27 → $43
Current: $11.04
Upside: n/a
Sep 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $525.00
Upside: n/a
Sep 15, 2020
Reiterated: Sell
Price Target: $14
Current: $30.15
Upside: n/a
Jul 7, 2020
Reiterated: Hold
Price Target: $16
Current: $50.77
Upside: n/a
Nov 7, 2019
Downgraded: Hold
Price Target: $16 → $4
Current: $0.0001
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $0.8239
Upside: n/a